These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37558297)

  • 1. Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias.
    Ryan T; Roberts JD
    Card Electrophysiol Clin; 2023 Sep; 15(3):261-271. PubMed ID: 37558297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Editing and Gene-Based Therapeutics for Cardiomyopathies.
    Ohiri JC; McNally EM
    Heart Fail Clin; 2018 Apr; 14(2):179-188. PubMed ID: 29525646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Strategies Targeting Inherited Cardiomyopathies.
    Varian K; Tang WHW
    Curr Heart Fail Rep; 2017 Aug; 14(4):321-330. PubMed ID: 28660543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid heart disease: genetics translated into disease-modifying therapy.
    Sperry BW; Tang WHW
    Heart; 2017 Jun; 103(11):812-817. PubMed ID: 28255101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.
    Asatryan B; Medeiros-Domingo A
    J Mol Med (Berl); 2018 Oct; 96(10):993-1024. PubMed ID: 30128729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials.
    Maurizi N; Ammirati E; Coppini R; Morrone A; Olivotto I
    Heart Fail Clin; 2018 Apr; 14(2):161-178. PubMed ID: 29525645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense technology: an emerging platform for cardiovascular disease therapeutics.
    Lee RG; Crosby J; Baker BF; Graham MJ; Crooke RM
    J Cardiovasc Transl Res; 2013 Dec; 6(6):969-80. PubMed ID: 23856914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
    Kaczmarek JC; Kowalski PS; Anderson DG
    Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
    Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.
    Marian AJ; Asatryan B; Wehrens XHT
    Cardiovasc Res; 2020 Jul; 116(9):1600-1619. PubMed ID: 32348453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).
    Doevendans PA; Glijnis PC; Kranias EG
    Circ Res; 2019 Sep; 125(7):720-724. PubMed ID: 31513489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
    Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B
    Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-based therapies for genodermatoses.
    Bornert O; Peking P; Bremer J; Koller U; van den Akker PC; Aartsma-Rus A; Pasmooij AM; Murauer EM; Nyström A
    Exp Dermatol; 2017 Jan; 26(1):3-10. PubMed ID: 27376675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.
    Castaño A; Drachman BM; Judge D; Maurer MS
    Heart Fail Rev; 2015 Mar; 20(2):163-78. PubMed ID: 25408161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene and Cell Therapy for Cardiac Arrhythmias.
    Ravindran D; Kok C; Farraha M; Selvakumar D; Clayton ZE; Kumar S; Chong J; Kizana E
    Clin Ther; 2020 Oct; 42(10):1911-1922. PubMed ID: 32988632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy, cardiomyopathies, and genetics.
    Van Tintelen JP; Pieper PG; Van Spaendonck-Zwarts KY; Van Den Berg MP
    Cardiovasc Res; 2014 Mar; 101(4):571-8. PubMed ID: 24451172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA therapeutics in ophthalmology - translation to clinical trials.
    Gupta A; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Exp Eye Res; 2021 Apr; 205():108482. PubMed ID: 33548256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid therapeutics in neurodevelopmental disease.
    Winkelsas AM; Fischbeck KH
    Curr Opin Genet Dev; 2020 Dec; 65():112-116. PubMed ID: 32623324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Clinical Aspects of Genetic Cardiomyopathies.
    Masarone D; Kaski JP; Pacileo G; Elliott PM; Bossone E; Day SM; Limongelli G
    Heart Fail Clin; 2018 Apr; 14(2):119-128. PubMed ID: 29525641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.